• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by NeueHealth Inc.

    10/2/25 9:38:31 AM ET
    $NEUE
    Medical Specialities
    Health Care
    Get the next $NEUE alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-40537
    Issuer: NeueHealth, Inc.
    Exchange: NEW YORK STOCK EXCHANGE LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 8000 Norman Center Drive, Suite 900
    Minneapolis MINNESOTA 55437
    Telephone number: 612-238-1321
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Common Stock
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2025-10-02 By Tyler Mastronardi Analyst, Market Watch
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $NEUE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NEUE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NEUE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NeueHealth Announces Closing of Take-Private Transaction

    NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today announced the successful closing of its previously announced merger under which NeueHealth has been acquired by an affiliate of New Enterprise Associates ("NEA") at an enterprise value of approximately $1.465 billion. Under the terms of the merger agreement, holders of NeueHealth common stock (other than shares that will be rolled over and certain excluded shares) will receive $7.33 per share in cash. Certain stockholders of NeueHeath, including NEA and 12 existing NeueHealth investors (which collectively hold all of the outstanding shares of NeueHealth preferred stock), have entered i

    10/2/25 9:16:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth Reports Second Quarter 2025 Results

    Delivered strong second quarter financial results, reflecting the continued success of consumer-centric care model and ability to create value for consumers, payors, and providers across the industry Drove positive Adjusted EBITDA for the sixth consecutive quarter, placing the company in a strong position to drive long-term, sustainable growth this year and beyond Served approximately 694,000 consumers, an increase of 45% over the second quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2025. "We are pleased to report another strong quarter of f

    8/7/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

    NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report second quarter financial results before the financial markets open on Thursday, August 7, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests parti

    7/17/25 8:00:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Matushak Jay returned 40,431 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/14/25 7:54:57 PM ET
    $NEUE
    Medical Specialities
    Health Care

    Large owner Bessemer Venture Partners Ix L.P. returned 999,218 shares to the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/6/25 7:45:32 PM ET
    $NEUE
    Medical Specialities
    Health Care

    Director Kraus Stephen returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/6/25 7:35:04 PM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    SEC Filings

    View All

    SEC Form 15-12G filed by NeueHealth Inc.

    15-12G - NeueHealth, Inc. (0001671284) (Filer)

    10/14/25 6:02:35 AM ET
    $NEUE
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by NeueHealth Inc.

    SCHEDULE 13D/A - NeueHealth, Inc. (0001671284) (Subject)

    10/6/25 5:00:02 PM ET
    $NEUE
    Medical Specialities
    Health Care

    SEC Form S-8 POS filed by NeueHealth Inc.

    S-8 POS - NeueHealth, Inc. (0001671284) (Filer)

    10/2/25 11:02:08 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Financials

    Live finance-specific insights

    View All

    NeueHealth Reports Second Quarter 2025 Results

    Delivered strong second quarter financial results, reflecting the continued success of consumer-centric care model and ability to create value for consumers, payors, and providers across the industry Drove positive Adjusted EBITDA for the sixth consecutive quarter, placing the company in a strong position to drive long-term, sustainable growth this year and beyond Served approximately 694,000 consumers, an increase of 45% over the second quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2025. "We are pleased to report another strong quarter of f

    8/7/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

    NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report second quarter financial results before the financial markets open on Thursday, August 7, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests parti

    7/17/25 8:00:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth Reports First Quarter 2025 Results

    Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another

    5/8/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by NeueHealth Inc. (Amendment)

    SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

    4/10/24 9:52:09 PM ET
    $NEUE
    Medical Specialities
    Health Care